SCHEMBL9460209

SCHEMBL9460209

CCCCCCCCCCCCCCCCCCNC(=O)OCC(COP(O)Oc1cccc(C[n+]2csc(C)c2)c1)OC(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9459089 1.00
SCHEMBL9459516 0.93
SCHEMBL9459761 0.93
SCHEMBL9459880 0.91 GMNN (0.35)
SCHEMBL9459603 0.91 GMNN (0.35)
SCHEMBL9459669 0.88 GMNN (0.44)
SCHEMBL9459247 0.88 GMNN (0.44)
SCHEMBL9459297 0.88 PTGS2 (0.38)
SCHEMBL9459269 0.88 PTGS2 (0.38)
SCHEMBL9459559 0.87

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5234918-A For cardiovascular, respiratory, carcinogenic and inflammatory disorders AMERICAN CYANAMID COMPANY (US) 1993-08-10 US disclosed
US-5215975-A Certain hydroxy-phosphinyl-oxy-phenyl methyl-thiazolium hydroxide inner salts as PAF antagonists AMERICAN CYANAMID COMPANY (US) 1993-06-01 US disclosed